US ETFDetailed Quotes

COYA Coya Therapeutics

Watchlist
  • 7.350
  • -0.010-0.14%
Close Jul 26 16:00 ET
111.88MMarket Cap-8546P/E (TTM)

Coya Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
126.84K
6M
6M
0
0
0
0
0
0
0
Operating revenue
--126.84K
--6M
--6M
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
92.57%5.58M
43.88%13.36M
147.53%3.99M
41.05%3.56M
-15.72%2.9M
70.56%2.9M
90.68%9.29M
0.96%1.61M
2.53M
3.45M
Selling and administrative expenses
46.84%2.44M
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
109.64%4.85M
22.74%898.65K
--1.24M
--1.99M
-General and administrative expense
46.84%2.44M
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
109.64%4.85M
22.74%898.65K
--1.24M
--1.99M
Research and development costs
154.78%3.14M
24.68%5.5M
127.34%1.61M
24.56%1.59M
-26.21%1.07M
25.84%1.23M
73.57%4.41M
-17.27%708.03K
--1.28M
--1.45M
Depreciation amortization depletion
0.00%6.84K
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
69.60%27.36K
-32.86%6.84K
--12.46K
--4.03K
-Depreciation and amortization
0.00%6.84K
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
69.60%27.36K
-32.86%6.84K
--12.46K
--4.03K
Operating profit
-88.20%-5.46M
20.75%-7.36M
224.47%2.01M
-41.05%-3.56M
15.72%-2.9M
-70.56%-2.9M
-90.68%-9.29M
-0.96%-1.61M
-2.53M
-3.45M
Net non-operating interest income expense
Other net income (expense)
148.17%406.09K
103.25%96.18K
98.76%-18.51K
109.51%142.09K
-673.92%-191.03K
5,523.73%163.63K
-13,668.91%-2.96M
-4,638.52%-1.49M
-1.49M
33.29K
Gain on sale of security
----
----
----
----
----
----
---2.5M
---1.12M
---1.4M
--22.35K
Special income (charges)
---25K
-3.46%-543.19K
50.47%-193.19K
--0
---350K
--0
---525K
---390K
---135K
--0
-Less:Other special charges
--25K
3.46%543.19K
-50.47%193.19K
----
--350K
----
--525K
--390K
--135K
----
Other non- operating income (expenses)
163.45%431.09K
904.14%639.37K
969.64%174.67K
260.45%142.09K
1,353.11%158.97K
5,523.73%163.63K
396.40%63.67K
151.79%16.33K
--39.42K
--10.94K
Income before tax
-84.61%-5.05M
40.68%-7.26M
164.03%1.99M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
-3.41M
Income tax
723.85K
0
Net income
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
-3.41M
Net income continuous Operations
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
---4.02M
---3.41M
Minority interest income
Net income attributable to the parent company
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
-3.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
-3.41M
Basic earnings per share
-25.00%-0.35
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
-538.47%-4.73
-30.09%-0.3211
-0.4154
-0.5169
Diluted earnings per share
-25.00%-0.35
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
-538.47%-4.73
-30.09%-0.3211
-0.4154
-0.5169
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 126.84K6M6M0000000
Operating revenue --126.84K--6M--6M--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 92.57%5.58M43.88%13.36M147.53%3.99M41.05%3.56M-15.72%2.9M70.56%2.9M90.68%9.29M0.96%1.61M2.53M3.45M
Selling and administrative expenses 46.84%2.44M61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M109.64%4.85M22.74%898.65K--1.24M--1.99M
-General and administrative expense 46.84%2.44M61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M109.64%4.85M22.74%898.65K--1.24M--1.99M
Research and development costs 154.78%3.14M24.68%5.5M127.34%1.61M24.56%1.59M-26.21%1.07M25.84%1.23M73.57%4.41M-17.27%708.03K--1.28M--1.45M
Depreciation amortization depletion 0.00%6.84K0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K69.60%27.36K-32.86%6.84K--12.46K--4.03K
-Depreciation and amortization 0.00%6.84K0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K69.60%27.36K-32.86%6.84K--12.46K--4.03K
Operating profit -88.20%-5.46M20.75%-7.36M224.47%2.01M-41.05%-3.56M15.72%-2.9M-70.56%-2.9M-90.68%-9.29M-0.96%-1.61M-2.53M-3.45M
Net non-operating interest income expense
Other net income (expense) 148.17%406.09K103.25%96.18K98.76%-18.51K109.51%142.09K-673.92%-191.03K5,523.73%163.63K-13,668.91%-2.96M-4,638.52%-1.49M-1.49M33.29K
Gain on sale of security ---------------------------2.5M---1.12M---1.4M--22.35K
Special income (charges) ---25K-3.46%-543.19K50.47%-193.19K--0---350K--0---525K---390K---135K--0
-Less:Other special charges --25K3.46%543.19K-50.47%193.19K------350K------525K--390K--135K----
Other non- operating income (expenses) 163.45%431.09K904.14%639.37K969.64%174.67K260.45%142.09K1,353.11%158.97K5,523.73%163.63K396.40%63.67K151.79%16.33K--39.42K--10.94K
Income before tax -84.61%-5.05M40.68%-7.26M164.03%1.99M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M-3.41M
Income tax 723.85K0
Net income -84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M-3.41M
Net income continuous Operations -84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M---4.02M---3.41M
Minority interest income
Net income attributable to the parent company -84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M-3.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M-3.41M
Basic earnings per share -25.00%-0.3583.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28-538.47%-4.73-30.09%-0.3211-0.4154-0.5169
Diluted earnings per share -25.00%-0.3583.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28-538.47%-4.73-30.09%-0.3211-0.4154-0.5169
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg